Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Sell
10
JDOC Quote, Financials, Valuation and Earnings
Last price:
$51.65
Seasonality move
:
8.19%
Day range:
$51.65 - $51.65
52-week range:
$50.95 - $63.49
Dividend yield:
5.45%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
--
1-year change:
-4.28%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$51.65 | -- | -- | -- | $0.33 | 5.45% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.48 | -- | -- | -- | $0.10 | 0.74% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$25.17 | -- | -- | -- | $0.01 | 0% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$31.18 | -- | -- | -- | $0.06 | 1.19% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$86.81 | -- | -- | -- | $0.62 | 1.49% | -- |
|
THW
Tekla World Healthcare Fund
|
$11.33 | -- | -- | -- | $0.12 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.904 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 1.308 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.784 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.894 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 0.694 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
JPMorgan Healthcare Leaders ETF vs. Competitors
-
Which has Higher Returns JDOC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About JDOC or AGNG?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Global X Aging Population ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is JDOC or AGNG More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock JDOC or AGNG?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.45%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or AGNG?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns JDOC or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is JDOC or BMED More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.45%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or BMED?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns JDOC or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About JDOC or HART?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is JDOC or HART More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or HART?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.45%. NYLI Healthy Hearts ETF offers a yield of 1.19% to investors and pays a quarterly dividend of $0.06 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or HART?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns JDOC or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About JDOC or IXJ?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is JDOC or IXJ More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.919%.
-
Which is a Better Dividend Stock JDOC or IXJ?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.45%. iShares Global Healthcare ETF offers a yield of 1.49% to investors and pays a quarterly dividend of $0.62 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or IXJ?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns JDOC or THW?
Tekla World Healthcare Fund has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About JDOC or THW?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Tekla World Healthcare Fund, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is JDOC or THW More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.302%.
-
Which is a Better Dividend Stock JDOC or THW?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.45%. Tekla World Healthcare Fund offers a yield of 0% to investors and pays a quarterly dividend of $0.12 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or THW?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
